tirzepatide heart disease and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Failure Management UC Irvine researchers project cardiac
Description
Common Side Effects and What to Expect GLP-1 medications can cause side effects, with gastrointestinal effects being the most common

"As an aspiring commercial trial lawyer, participating in moot court has been one of the most transformative experiences of my time at Miami Law

Well monitor your progress through regular follow-up appointments and make any necessary dose adjustments, and provide ongoing support to address questions or concerns

+ LeanDose Team LeanDose supports an online intake and provider-review flow

Significant fluctuations, if not well-controlled, can lead to diabetic retinopathy
GLP-1 receptor agonists slow gastric emptying but do not directly interact with reproductive hormones like oestrogen or progesterone Semaglutide (Wegovy) and liraglutide (Saxenda) do not require routine additional contraceptive precautions based on current evidence Tirzepatide reduces oral contraceptive exposure and requires barrier methods or non-oral contraception for 4 weeks after starting and after each dose increase Long-acting reversible contraceptives (IUDs, implants) are unaffected by gastric emptying and provide highly reliable alternatives during weight loss treatment Gastrointestinal side effects such as vomiting within 3 hours of taking oral contraceptives may compromise absorption and require missed pill guidance Weight loss medications should be discontinued before planned conception (typically 12 months depending on the specific agent) Table of Contents How Weight Loss Injections Work in Your Body Weight loss injections prescribed in the UK typically contain glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Wegovy) or liraglutide (Saxenda), or dual GIP/GLP-1 receptor agonists like tirzepatide
